Medicine Overview of Olmecip AM Tablet
Nausea, Altered taste, Diarrhoea, Stomach upset, Ankle swelling, Headache, Dizziness, Weakness, Numbness of extremity, Edema (swelling), Flushing of skin, Increased potassium level in blood, Decreased blood pressure.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Olmecip AM 20 mg/5 mg Tablet may be taken with or without food, but it is better to take it at a fixed time.
Olmecip AM 20 mg/5 mg Tablet is a combination of two medicines: Olmesartan and Amlodipine which lower blood pressure effectively. Olmesartan is an angiotensin receptor blocker (ARB) and Amlodipine is a calcium channel blocker (CCB). They work by relaxing the blood vessels and making the heart more efficient at pumping blood throughout the body.
In Depth Information on Olmecip AM Tablet
Olmecip AM Tablet related warnings
WEIGH RISKS VS BENEFITS
Olmecip AM 20 mg/5 mg Tablet is unsafe to use during pregnancy.
There is positive evidence of human fetal risk, but the benefits from use in pregnant women may be acceptable despite the risk, for example in life-threatening situations. Please consult your doctor.
Olmecip AM 20 mg/5 mg Tablet is probably safe to use during lactation.
Limited human data suggests that the drug does not represent a significant risk to the baby.
Do not drive unless you are feeling well.
Olmecip AM 20 mg/5 mg Tablet may cause side effects such as dizziness, headaches, nausea or tiredness, all of which could affect your ability to concentrate and drive.
Olmecip AM 20 mg/5 mg Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of Olmecip AM 20 mg/5 mg Tablet may be needed. Please consult your doctor.
Regular monitoring of blood pressure is advisable for dose adjustment.
Olmecip AM 20 mg/5 mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Olmecip AM 20 mg/5 mg Tablet may be needed. Please consult your doctor.
Olmecip AM 20 mg/5 mg Tablet is started at a lower dose in patients with liver disease and further increased slowly with careful monitoring.
No Patient Concerns found for this medicine
User Submitted Feedback For Olmecip AM 20 mg/5 mg Tablet
Patients taking Olmecip AM 20 mg/5 mg Tablet What are you using Olmecip AM Tablet for?
Survey Participants: 2
“The following are the results of on-going survey on 1mg.com for Olmecip AM 20 mg/5 mg Tablet. These results only indicate the perceptions of the website users. Please base your medical decisions only on the advice of a doctor or a registered medical professional.”
One of the following vendor pharmacies will deliver Olmecip AM 20 mg/5 mg Tablet: ABP, BAL, RPP, SDM, BTM, SJP, HPC, KMC, ESY, HGI, SBA, MDO, TRP, HNP, ZVP, SAF, WHL, SVH, HBV, LHA, JIV, MMS, QTM, IAD, DPP, RSA, RDH, BHP, HSP, GPT, NVL, KHC, CLT, DVH, UMP, AGT, VNS, RDR, THP, PPR, HIP, RUS, IPL, MAK, GTK, SHP, ARD, JSL, STA, NDP, MAX, ATL, DAO, MLC, SBL, DFP, VDH, MDH, HAT, OWP, AAY, RPI, DLP, AAR, SGH, PLT, AYU, SHD, NSL, SWA, GNC, GTC, PTI, TNH, MPC, SWP, DYG, SCH, GPP, SVS, DHR, PVP, KHH, RSS, BLE, ADT, PRN, SLN, PEN, NAS, RWP, SSA, BIO, HTS, LCC, EQN, EMB, GHR, BMJ, TOM, JVN, DGN, RJH, SYN, BBS, ATP, OIP, MSD, SHC, MAM, BSN, DPL, PNT, RHW, HZF, 9T9, P2P, NXG, VRS, BDN, GBL, EVP, RHL, USF, TFP, RKS, JVO, BHM, SRG, SGC, HEX, PMA, INC, ANT, OLT, QLF, SPD, WSI, AMR, ENP, NVY, OHM, PWN, ZEL, HMP, BAP, AYM, FGH, NTB, NNH